SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001113148-16-000007
Filing Date
2016-05-04
Accepted
2016-05-04 15:44:27
Documents
55
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q infi-20160331x10q.htm 10-Q 924762
2 EX-10.1 ex101amend6to2010plan.htm EX-10.1 8255
3 EX-31.1 ex-311.htm EX-31.1 10541
4 EX-31.2 ex-312.htm EX-31.2 11801
5 EX-32.1 ex-321.htm EX-32.1 6041
6 EX-32.2 ex-322.htm EX-32.2 6100
  Complete submission text file 0001113148-16-000007.txt   4071373

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT infi-20160331.xml EX-101.INS 565326
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT infi-20160331.xsd EX-101.SCH 47877
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT infi-20160331_cal.xml EX-101.CAL 56326
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT infi-20160331_def.xml EX-101.DEF 167134
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT infi-20160331_lab.xml EX-101.LAB 522701
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT infi-20160331_pre.xml EX-101.PRE 267631
Mailing Address 784 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 784 MEMORIAL DRIVE CAMBRIDGE MA 02139 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31141 | Film No.: 161619163
SIC: 2834 Pharmaceutical Preparations